A Prospective Pilot Study on Use of Liquid Crystal Thermography to Detect Early Breast Cancer

<b>Background:</b> Breast cancer is the most common cancer in women. While mammography is the standard for early detection in women older than 50 years of age, there is no standard for younger women. The aim of this prospective pilot study was to assess liquid crystal contact thermography, using the Braster device, as a means for the early detection of breast cancer. The device is intended to be used as a complementary tool to standard of care (sonography, mammography, etc). <b>Patients and Methods:</b> A total of 274 consecutive women presenting at Polish breast centers for prophylactic breast examination were enrolled to receive thermography; 19 were excluded for errors in thermographic image acquisition. The women were divided according to age (n = 135, <50 years; n = 120, ≥50 years). A control population was included (n = 40, <50 years; n = 23, ≥50 years). The primary endpoint, stratified by age group, was the <i>C</i>-statistic for discrimination between breast cancer and noncancer. <b>Results:</b> In women with abnormal breast ultrasound (n = 95, <50 years; n = 87, ≥50 years), the <i>C</i>-statistic was 0.85 and 0.75, respectively (<i>P</i> = .20), for discrimination between breast cancer and noncancer. Sensitivity did not differ (<i>P</i> = .79) between the younger (82%) and older women (78%), while specificity was lower in the older women (60% vs 87%, <i>P</i> = .025). The false-positive rate was similar in women with normal and abnormal breast ultrasound. Positive thermographic result in women with Breast Imaging Reporting and Data System (BIRADS) 4A on ultrasound increased the probability of breast cancer by over 2-fold. Conversely, a negative thermographic result decreased the probability of cancer more than 3-fold. Breast size and structure did not affect the thermography performance. No adverse events were observed. <b>Conclusions:</b> Thermography performed well in women <50 years of age, while its specificity in women ≥50 years was inadequate. These promising findings suggest that the Braster device deserves further investigation as a supporting tool for the early detection of breast cancer in women younger than 50 years of age.